about
MicroRNAs in breast cancer initiation and progressionDownregulation of miRNA-200c links breast cancer stem cells with normal stem cellsMacrophage contact induces RhoA GTPase signaling to trigger tumor cell intravasation.Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse modelsElevated poly-(ADP-ribose)-polymerase activity sensitizes retinoblastoma-deficient cells to DNA damage-induced necrosisDevelopment of a Fluorescent Reporter System to Delineate Cancer Stem Cells in Triple-Negative Breast Cancer.MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion.A rapid, automated surface protein profiling of single circulating exosomes in human blood.14q32-encoded microRNAs mediate an oligometastatic phenotype.Overview of Cancer Stem Cells and Stemness for Community Oncologists.Grape seed proanthocyanidins ameliorate Doxorubicin-induced cardiotoxicity.A novel form of pRb expressed during normal myelopoiesis and in tumour-associated macrophages.miR-206 Inhibits Stemness and Metastasis of Breast Cancer by Targeting MKL1/IL11 Pathway.New Advances and Challenges of Targeting Cancer Stem Cells.New Opportunities and Challenges to Defeat Cancer Stem Cells.Cx26 drives self-renewal in triple-negative breast cancer via interaction with NANOG and focal adhesion kinase.Advances, challenges, and opportunities in extracellular RNA biology: insights from the NIH exRNA Strategic Workshop.Exosomes as a Drug Delivery System in Cancer Therapy: Potential and ChallengesRegulation and functions of integrin α2 in cell adhesion and diseaseExtracellular Domains I and II of cell-surface glycoprotein CD44 mediate its trans-homophilic dimerization and tumor cluster aggregation
P50
Q26823360-902C6381-ED05-4ACE-A396-632AF2438985Q29619847-33ACFA1A-6E63-43B1-8CE5-C7E9819884DDQ30574501-60590ED4-AE87-478B-911F-0F5378D069CDQ34241451-828A7FF1-E85B-4729-BC89-9ED57D0B8966Q34367282-39C67156-3D76-4FFC-A4A8-AB649198D4ADQ35827788-BC679A2B-284D-4221-95EB-E628F2C0585AQ36641467-AD244D4A-4B55-4F6B-9BD9-222C9624A8E3Q37397211-9E67BCFB-584A-4285-BA20-A5A1E84B4EBFQ38909005-5DFA83D6-B111-4F18-A3D5-6C7EE7107F8FQ39406329-0E5B0E09-A2A8-4246-AB0C-201B176B07ABQ39700191-4046F4B9-ECEC-4F73-83CB-631BD2C66DC5Q40464151-60765113-EE67-45AE-8338-73BCA726F8CEQ46142063-29ECEA8A-DCB8-447F-9B6D-0E91AB06DFF5Q48588244-F2EDD865-8089-451E-9B46-F8E78D675E41Q50094787-2E67CC67-D47B-4A6E-AC35-4FCE007DFF05Q50106997-FF04D432-4D33-4816-A54D-2B960A370B46Q52331794-45E8AB07-210A-4DCC-A3F6-9896E469A359Q88713626-E8C3B557-49D3-4F6F-BF7B-A10513D1D24FQ92587248-FCED4AE7-E356-4D53-9123-EA16E4E85860Q92859006-E3F17C54-4F0A-47A4-ADCE-986AEEAF8AE3
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-4822-7995
@en
name
Huiping Liu
@ast
Huiping Liu
@en
Huiping Liu
@es
Huiping Liu
@nl
type
label
Huiping Liu
@ast
Huiping Liu
@en
Huiping Liu
@es
Huiping Liu
@nl
prefLabel
Huiping Liu
@ast
Huiping Liu
@en
Huiping Liu
@es
Huiping Liu
@nl
P106
P31
P496
0000-0003-4822-7995